+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Uveitis Treatment Market by Type of Treatment, End-user, Application, Drug Type, Patient Demographics, Route of Administration, Disease Causation, Therapeutic Class, Diagnostic Methods - Global Forecast 2025-2030- Product Image
Uveitis Treatment Market by Type of Treatment, End-user, Application, Drug Type, Patient Demographics, Route of Administration, Disease Causation, Therapeutic Class, Diagnostic Methods - Global Forecast 2025-2030- Product Image
Sale

Uveitis Treatment Market by Type of Treatment, End-user, Application, Drug Type, Patient Demographics, Route of Administration, Disease Causation, Therapeutic Class, Diagnostic Methods - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • November 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888962
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Uveitis Treatment Market grew from USD 724.65 million in 2023 to USD 783.24 million in 2024. It is expected to continue growing at a CAGR of 8.48%, reaching USD 1.28 billion by 2030.

Uveitis treatment refers to the medical interventions designed to manage and alleviate inflammation of the uvea, the eye's middle layer, which can cause vision impairment and other severe complications if untreated. The necessity of uveitis treatment stems from its potential to lead to blindness, making early diagnosis and efficient management crucial. Applications of uveitis treatment extend across pharmaceuticals, such as corticosteroids and immunosuppressants, as well as surgical interventions for more severe cases. End-use primarily involves hospitals, ophthalmology clinics, and academic research institutions.

Key driving factors influencing market growth include an increasing prevalence of uveitis, advancements in drug delivery technologies, and rising awareness about eye health. Opportunities arise in emerging markets where healthcare infrastructure is improving, as well as through the development of biologics and biosimilars offering enhanced efficacy with reduced side effects. Companies have an opportunity to focus on personalized medicine approaches, tailoring treatments based on genetic and biomarker profiles to improve patient outcomes.

Challenges include the high cost of treatment, side effects associated with long-term use of corticosteroids, and delays in diagnosis due to a lack of awareness. Additionally, the complexity of diseases and the heterogeneous nature of uveitis make standardized treatment challenging. Limitations such as regulatory hurdles and the slow approval process for new drugs also impede market progress. Areas of innovation include gene therapy, novel drug delivery systems like ocular implants, and non-invasive diagnostic tools that facilitate early detection. Research focusing on understanding the genetic pathways involved in uveitis can lead to breakthroughs in treatment approaches.

The market's nature is dynamic, with a steady influx of new research and emerging technologies, requiring players to remain agile and informed about global trends. Establishing strong partnerships with healthcare providers and investing in robust R&D programs are recommended strategies for companies looking to solidify their presence and grow in this competitive landscape.

Understanding Market Dynamics in the Uveitis Treatment Market

The Uveitis Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Understanding the current catalysts boosting the uveitis treatment market on a global scale
    • Market dynamics shaping the future of uveitis treatments and therapeutic breakthroughs
    • Critical components contributing to the increased funding and research in uveitis treatment options
  • Market Restraints
    • Recognizing patient adherence issues as a significant obstacle in the uveitis treatment journey
    • Evaluating the limitations in accurate diagnosis affecting uveitis treatment outcomes and market demand
    • Analyzing the insufficiency of real-world efficacy data as a hurdle in gaining market confidence
  • Market Opportunities
    • Amplified patient advocacy prompting more robust clinical trials focused on uveitis therapeutic outcomes
    • Growing patient-centric approaches in healthcare placing emphasis on quality care for uveitis sufferers
    • Growing acceptance of precision medicine encouraging personalized treatment plans for uveitis patients
  • Market Challenges
    • Improving patient adherence to prescribed uveitis treatment regimens for better outcomes
    • Navigating complex regulatory pathways and approval processes for new uveitis treatments
    • Encouraging collaboration and data sharing between researchers in the uveitis treatment landscape

Exploring Porter’s Five Forces for the Uveitis Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Uveitis Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Uveitis Treatment Market

External macro-environmental factors deeply influence the performance of the Uveitis Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Uveitis Treatment Market

The Uveitis Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Uveitis Treatment Market

The Uveitis Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Uveitis Treatment Market

The Uveitis Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uveitis Treatment Market, highlighting leading vendors and their innovative profiles. These include Accutome, Inc., Ajanta Pharma Ltd., Alcon Vision LLC, Allergan PLC, Amorphex Therapeutics Holdings, Inc., Appasamy Ocular Device Pvt Ltd., Astellas Pharma Inc., Bausch & Lomb Incorporated, Bayer AG, Cipla Ltd., Entod Pharmaceuticals Ltd., EyePoint Pharmaceuticals, Inc., Fera Pharmaceuticals, His Eyeness Ophthalmics Pvt Ltd., Intas Pharmaceuticals Ltd., J B Chemicals And Pharmaceuticals Ltd., Kubota Vision Inc., Merck & Co. Inc., Micro Labs Ltd., Nidek Co Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sunways India Pvt Ltd., and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Uveitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type of Treatment
    • Alternative Therapy
      • Acupuncture
      • Herbal Remedies
      • Yoga
    • Medication
      • Biologics
      • Corticosteroids
      • Immunosuppressants
    • Surgical Intervention
      • Laser Therapy
      • Vitrectomy
  • End-User
    • Homecare Settings
    • Hospitals
    • Specialty Clinics
  • Application
    • Anterior Uveitis
    • Intermediate Uveitis
    • Panuveitis
      • Infectious Panuveitis
      • Non-Infectious Panuveitis
    • Posterior Uveitis
  • Drug Type
    • Branded Drugs
    • Generic Drugs
  • Patient Demographics
    • Adult Patients
    • Geriatric Patients
    • Pediatric Patients
  • Route of Administration
    • Intravenous
    • Intravitreal Injection
    • Oral
    • Topical
  • Disease Causation
    • Autoimmune Disorders
    • Drug-Induced
    • Infectious Causes
  • Therapeutic Class
    • Analgesics
    • Anti-Inflammatory Agents
    • Antibiotics
  • Diagnostic Methods
    • Blood Tests
    • Eye Examination
    • Fundoscopy
    • Ultrasonography
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  • Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  • Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  • Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  • Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  • Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  • What is the current size of the market, and how is it expected to grow?
  • Which products, segments, and regions present the most attractive investment opportunities?
  • What are the prevailing technology trends and regulatory factors influencing the market?
  • How do top vendors rank regarding market share and competitive positioning?
  • What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Understanding the current catalysts boosting the uveitis treatment market on a global scale
5.1.1.2. Market dynamics shaping the future of uveitis treatments and therapeutic breakthroughs
5.1.1.3. Critical components contributing to the increased funding and research in uveitis treatment options
5.1.2. Restraints
5.1.2.1. Recognizing patient adherence issues as a significant obstacle in the uveitis treatment journey
5.1.2.2. Evaluating the limitations in accurate diagnosis affecting uveitis treatment outcomes and market demand
5.1.2.3. Analyzing the insufficiency of real-world efficacy data as a hurdle in gaining market confidence
5.1.3. Opportunities
5.1.3.1. Amplified patient advocacy prompting more robust clinical trials focused on uveitis therapeutic outcomes
5.1.3.2. Growing patient-centric approaches in healthcare placing emphasis on quality care for uveitis sufferers
5.1.3.3. Growing acceptance of precision medicine encouraging personalized treatment plans for uveitis patients
5.1.4. Challenges
5.1.4.1. Improving patient adherence to prescribed uveitis treatment regimens for better outcomes
5.1.4.2. Navigating complex regulatory pathways and approval processes for new uveitis treatments
5.1.4.3. Encouraging collaboration and data sharing between researchers in the uveitis treatment landscape
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Uveitis Treatment Market, by Type of Treatment
6.1. Introduction
6.2. Alternative Therapy
6.2.1. Acupuncture
6.2.2. Herbal Remedies
6.2.3. Yoga
6.3. Medication
6.3.1. Biologics
6.3.2. Corticosteroids
6.3.3. Immunosuppressants
6.4. Surgical Intervention
6.4.1. Laser Therapy
6.4.2. Vitrectomy
7. Uveitis Treatment Market, by End-User
7.1. Introduction
7.2. Homecare Settings
7.3. Hospitals
7.4. Specialty Clinics
8. Uveitis Treatment Market, by Application
8.1. Introduction
8.2. Anterior Uveitis
8.3. Intermediate Uveitis
8.4. Panuveitis
8.4.1. Infectious Panuveitis
8.4.2. Non-Infectious Panuveitis
8.5. Posterior Uveitis
9. Uveitis Treatment Market, by Drug Type
9.1. Introduction
9.2. Branded Drugs
9.3. Generic Drugs
10. Uveitis Treatment Market, by Patient Demographics
10.1. Introduction
10.2. Adult Patients
10.3. Geriatric Patients
10.4. Pediatric Patients
11. Uveitis Treatment Market, by Route of Administration
11.1. Introduction
11.2. Intravenous
11.3. Intravitreal Injection
11.4. Oral
11.5. Topical
12. Uveitis Treatment Market, by Disease Causation
12.1. Introduction
12.2. Autoimmune Disorders
12.3. Drug-Induced
12.4. Infectious Causes
13. Uveitis Treatment Market, by Therapeutic Class
13.1. Introduction
13.2. Analgesics
13.3. Anti-Inflammatory Agents
13.4. Antibiotics
14. Uveitis Treatment Market, by Diagnostic Methods
14.1. Introduction
14.2. Blood Tests
14.3. Eye Examination
14.4. Fundoscopy
14.5. Ultrasonography
15. Americas Uveitis Treatment Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Uveitis Treatment Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Uveitis Treatment Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2023
18.2. FPNV Positioning Matrix, 2023
18.3. Competitive Scenario Analysis
18.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. UVEITIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. UVEITIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. UVEITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. UVEITIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 19. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2023 VS 2030 (%)
FIGURE 21. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
FIGURE 23. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2023 VS 2030 (%)
FIGURE 25. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 29. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 30. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 31. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 34. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 35. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. UVEITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. UVEITIS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY YOGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INFECTIOUS PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY NON-INFECTIOUS PANUVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DRUG-INDUCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INFECTIOUS CAUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY EYE EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY FUNDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ULTRASONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 99. CANADA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. CANADA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 101. CANADA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 102. CANADA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 103. CANADA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 106. CANADA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 108. CANADA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 111. CANADA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 115. MEXICO UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. MEXICO UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 123. MEXICO UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 166. CHINA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. CHINA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 168. CHINA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 169. CHINA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 170. CHINA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. CHINA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. CHINA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 173. CHINA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. CHINA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 175. CHINA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. CHINA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 177. CHINA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 178. CHINA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 179. INDIA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. INDIA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 181. INDIA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 182. INDIA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 183. INDIA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. INDIA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDIA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 186. INDIA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 187. INDIA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 188. INDIA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. INDIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 190. INDIA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 191. INDIA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 205. JAPAN UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 206. JAPAN UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 207. JAPAN UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 208. JAPAN UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 209. JAPAN UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. JAPAN UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. JAPAN UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 212. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 213. JAPAN UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 214. JAPAN UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 216. JAPAN UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 217. JAPAN UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 284. THAILAND UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 285. THAILAND UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. THAILAND UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. THAILAND UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 292. THAILAND UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 294. THAILAND UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 295. THAILAND UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 323. DENMARK UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 324. DENMARK UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 325. DENMARK UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 326. DENMARK UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 327. DENMARK UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. DENMARK UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. DENMARK UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, 2018-2030 (USD MILLION)
TABLE 330. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 331. DENMARK UVEITIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 332. DENMARK UVEITIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 333. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DISEASE CAUSATION, 2018-2030 (USD MILLION)
TABLE 334. DENMARK UVEITIS TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 335. DENMARK UVEITIS TREATMENT MARKET SIZE, BY DIAGNOSTIC METHODS, 2018-2030 (USD MILLION)
TABLE 336. EGYPT UVEITIS TREATMENT MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 337. EGYPT UVEITIS TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 338. EGYPT UVEITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 339. EGYPT UVEITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 340. EGYPT UVEITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 341. EGYPT UVEITIS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

Companies Mentioned

  • Accutome, Inc.
  • Ajanta Pharma Ltd.
  • Alcon Vision LLC
  • Allergan PLC
  • Amorphex Therapeutics Holdings, Inc.
  • Appasamy Ocular Device Pvt Ltd.
  • Astellas Pharma Inc.
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Cipla Ltd.
  • Entod Pharmaceuticals Ltd.
  • EyePoint Pharmaceuticals, Inc.
  • Fera Pharmaceuticals
  • His Eyeness Ophthalmics Pvt Ltd.
  • Intas Pharmaceuticals Ltd.
  • J B Chemicals And Pharmaceuticals Ltd.
  • Kubota Vision Inc.
  • Merck & Co. Inc.
  • Micro Labs Ltd.
  • Nidek Co Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sunways India Pvt Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 783.24 million
Forecasted Market Value ( USD ) by 2030 $ 1281.23 million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Anterior Uveitis Treatment Market by Treatment Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Anterior Uveitis Treatment Market by Treatment Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Uveitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Uveitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Uveitis Treatment Market Report by Treatment Type, Disease Type, Cause, Distribution Channel, and Region 2024-2032 - Product Image

Uveitis Treatment Market Report by Treatment Type, Disease Type, Cause, Distribution Channel, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Uveitis Treatment Market - Product Image

Uveitis Treatment Market

  • Report
  • 200 Pages
  • Global
From

About the Uveitis Drug Market

Uveitis is an inflammatory condition of the eye that can cause vision loss and other complications. Immune disorders drugs are used to treat uveitis and other immune-mediated diseases. These drugs are designed to reduce inflammation and suppress the immune system. Commonly used drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and reduce inflammation. The uveitis drug market is a rapidly growing segment of the immune disorders drugs market. It is driven by the increasing prevalence of uveitis and other immune-mediated diseases, as well as the development of new drugs and treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.